Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cyclo Therapeutics Inc (NQ: CYTH ) 0.8277 +0.0477 (+6.12%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 102,512 Open 0.7913 Bid (Size) 0.8011 (10) Ask (Size) 0.8300 (20) Prev. Close 0.7800 Today's Range 0.7913 - 0.8588 52wk Range 0.7677 - 2.115 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH August 26, 2024 From Kahn Swick & Foti, LLC Via Business Wire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, SDIG, ARCH, CYTH on Behalf of Shareholders August 24, 2024 From Halper Sadeh LLC Via GlobeNewswire Performance YTD -50.14% -50.14% 1 Month -29.86% -29.86% 3 Month -35.34% -35.34% 6 Month -51.31% -51.31% 1 Year -44.45% -44.45% More News Read More Nasdaq Down Over 200 Points; Williams-Sonoma Shares Tumble After Q2 Results August 22, 2024 Via Benzinga Gold Down Over 1%; US Initial Jobless Claims Increase August 22, 2024 Via Benzinga CYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to Shareholders August 22, 2024 From Halper Sadeh LLC Via Business Wire Dow Jumps 100 Points; BJ's Wholesale Earnings Top Estimates August 22, 2024 Via Benzinga Topics Stocks Exposures US Equities Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement August 22, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement August 22, 2024 From Rafael Holdings, Inc.; Cyclo Therapeutics Via GlobeNewswire CYTH Stock Earnings: Cyclo Therapeutics Misses EPS, Misses Revenue for Q2 2024 August 15, 2024 Via InvestorPlace Cyclo Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update August 15, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Announces Notice of Decision to Grant European Patent Application for Treatment of Alzheimer’s Disease from European Patent Office July 29, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024 June 25, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results June 14, 2024 From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1 May 30, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update May 16, 2024 From Cyclo Therapeutics, Inc. Via Business Wire CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q1 2024 May 16, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session April 18, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session April 02, 2024 Via Benzinga CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023 March 19, 2024 Via InvestorPlace Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update March 18, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease March 14, 2024 From Cyclo Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's After-Market Session March 13, 2024 Via Benzinga Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results March 13, 2024 From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office January 29, 2024 From Cyclo Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's Intraday Session January 15, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.